PMID: 8604176Jan 17, 1996Paper

Measles elimination in the Americas. Evolving strategies

JAMA : the Journal of the American Medical Association
C A de QuadrosG A Alleyne

Abstract

The strategy currently used to control measles in most countries has been to immunize each successive birth cohort through the routine health services delivery system. While measles vaccine coverage has increased markedly, significant measles outbreaks have continued to recur. During the past 5 years, experience in the Americas suggests that measles transmission has been interrupted in a number of countries (Cuba, Chile, and countries in the English-speaking Caribbean and successfully controlled in all remaining countries. Since 1991 these countries have implemented one-time "catch-up" vaccination campaigns (conducted during a short period, usually 1 week to 1 month, and targeting all children 9 months through 14 years of age, regardless of previous vaccination status or measles disease history). These campaigns have been followed by improvements in routine vaccination services and in surveillance systems, so that the progress of the measles elimination efforts can be sustained and monitored. Follow-up mass vaccination campaigns for children younger than 5 years are planned to take place every 3 to 5 years.

Citations

Jun 6, 2002·Lancet·Robin BiellikJean-Marie Okwo-Bele
Jun 10, 2011·Indian Pediatrics·Satish Kumar GuptaAnindya Sekhar Bose
Sep 14, 2001·Tropical Medicine & International Health : TM & IH·N IshiwadaB D Akanmori
Oct 13, 2000·American Journal of Public Health·B AylwardS Cochi
Oct 13, 2000·American Journal of Public Health·W A OrensteinS L Cochi
Aug 5, 1999·American Journal of Public Health·J M HirshonB S Hersh
Sep 28, 2001·American Journal of Public Health·D G KoopG Nestel
Oct 1, 1996·Emerging Infectious Diseases·M A Winker
Jun 1, 1997·American Journal of Public Health·C E TaylorM E Taylor
Apr 8, 1998·BMJ : British Medical Journal·F T Cutts, R Steinglass
Nov 19, 2008·BMC Public Health·Jagrati V JaniIlesh V Jani
Jan 15, 2009·Bulletin of the World Health Organization·Hitoshi MurakamiDo Si Hien
Feb 6, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Scott M Duke-SylvesterLeslie A Real
Dec 16, 1998·Australian and New Zealand Journal of Public Health·M Patel, D Lush
May 2, 2003·The Journal of Infectious Diseases·D Rebecca PrevotsJarbas Barbosa Da Silva
May 2, 2003·The Journal of Infectious Diseases·Ciro A De QuadrosGina Tambini
May 2, 2003·The Journal of Infectious Diseases·Rosario QuirogaHéctor Izurieta
May 2, 2003·The Journal of Infectious Diseases·T GaafarF Lievano
May 2, 2003·The Journal of Infectious Diseases·Mac W OttenDeogratias Nshimirimana
May 2, 2003·The Journal of Infectious Diseases·Ana-Maria Henao-RestrepoJulian Bilous
May 2, 2003·The Journal of Infectious Diseases·Alejandro CostaEdward John Hoekstra
May 2, 2003·The Journal of Infectious Diseases·Mary E RamsayDavid Brown
May 2, 2003·The Journal of Infectious Diseases·Daniel A KerteszFlabou Bougoudogo
May 2, 2003·The Journal of Infectious Diseases·Miriam NanyunjaAmbrose Talisuna
May 2, 2003·The Journal of Infectious Diseases·Paul A Rota, William J Bellini
May 2, 2003·The Journal of Infectious Diseases·K Robert YaméogoPatrick L F Zuber
May 2, 2003·The Journal of Infectious Diseases·Héctor IzurietaCiro A de Quadros
May 2, 2003·The Journal of Infectious Diseases·Peter StrebelSamuel Katz
May 2, 2003·The Journal of Infectious Diseases·Bradley S HershJulian B Bilous
Apr 24, 2004·The Journal of Infectious Diseases·Jose Ignacio SantosRoberto Tapia Conyer
Apr 24, 2004·The Journal of Infectious Diseases·Peter M StrebelStephen L Cochi
Apr 24, 2004·The Journal of Infectious Diseases·Ciro A de QuadrosPeter Carrasco
Apr 24, 2004·The Journal of Infectious Diseases·Nigel J Gay
Nov 17, 2007·The Journal of Infectious Diseases·Walter A OrensteinAlan R Hinman
Aug 1, 2008·Medicinski pregled·Zorica SeguljevSvetlana Ilić
Aug 15, 2013·Indian Pediatrics·V M VashishthaS G Gupta
Jul 17, 1998·Annals of Medicine·O P HeinonenH Peltola
Apr 18, 2012·Vaccine·Jean-Marie Okwo-Bele, Thomas Cherian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.